Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Can we avoid the toxicity of chemotherapy in elderly cancer patients?

Feliu J, Heredia-Soto V, Gironés R, Jiménez-Munarriz B, Saldaña J, Guillén-Ponce C, Molina-Garrido MJ.

Crit Rev Oncol Hematol. 2018 Nov;131:16-23. doi: 10.1016/j.critrevonc.2018.08.008. Epub 2018 Aug 28. Review.

PMID:
30293701
2.

Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review.

Versteeg KS, Konings IR, Lagaay AM, van de Loosdrecht AA, Verheul HM.

Ann Oncol. 2014 Oct;25(10):1914-8. doi: 10.1093/annonc/mdu052. Epub 2014 Feb 25.

PMID:
24569912
3.

Risk Factors for Chemotherapy-Related Toxicity and Adverse Events in Elderly Thai Cancer Patients: A Prospective Study.

Phaibulvatanapong E, Srinonprasert V, Ithimakin S.

Oncology. 2018;94(3):149-160. doi: 10.1159/000485078. Epub 2017 Dec 7.

PMID:
29212082
4.

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.

Hamaker ME, Seynaeve C, Wymenga AN, van Tinteren H, Nortier JW, Maartense E, de Graaf H, de Jongh FE, Braun JJ, Los M, Schrama JG, van Leeuwen-Stok AE, de Groot SM, Smorenburg CH.

Breast. 2014 Feb;23(1):81-7. doi: 10.1016/j.breast.2013.11.004. Epub 2013 Dec 5.

5.

Toxicity of Cancer Therapies in Older Patients.

Le Saux O, Falandry C.

Curr Oncol Rep. 2018 Jun 13;20(8):64. doi: 10.1007/s11912-018-0705-y. Review.

PMID:
29896642
6.

Determining chemotherapy tolerance in older patients with cancer.

Kim J, Hurria A.

J Natl Compr Canc Netw. 2013 Dec 1;11(12):1494-502. Review.

7.

Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients.

Feliu J, Heredia-Soto V, Gironés R, Jiménez-Munarriz B, Saldaña J, Guillén-Ponce C, Molina-Garrido MJ.

Clin Transl Oncol. 2019 Jun 25. doi: 10.1007/s12094-019-02167-y. [Epub ahead of print] Review.

PMID:
31240462
8.

The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer.

Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC.

Oncologist. 2012;17(11):1439-49. doi: 10.1634/theoncologist.2012-0186. Epub 2012 Aug 31. Review.

9.

Greater risks of chemotherapy toxicity in elderly patients with cancer.

Repetto L.

J Support Oncol. 2003 Nov-Dec;1(4 Suppl 2):18-24. Review.

PMID:
15346996
10.

Therapy insight: Therapeutic challenges in the treatment of elderly cancer patients.

Lichtman SM.

Nat Clin Pract Oncol. 2006 Feb;3(2):86-93. Review.

PMID:
16462849
11.

Tolerance to chemotherapy in elderly patients with cancer.

Wedding U, Honecker F, Bokemeyer C, Pientka L, Höffken K.

Cancer Control. 2007 Jan;14(1):44-56. Review.

PMID:
17242670
12.

Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction.

Rao AV.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):339-347. Review.

13.

The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).

Lund CM, Vistisen KK, Dehlendorff C, Rønholt F, Johansen JS, Nielsen DL.

BMC Cancer. 2017 Jun 28;17(1):448. doi: 10.1186/s12885-017-3445-8.

14.

Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer.

Quoix E.

Drugs Aging. 2011 Nov 1;28(11):885-94. doi: 10.2165/11595100-000000000-00000. Review.

PMID:
22054229
15.

Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?

Antonio M, Saldaña J, Carmona-Bayonas A, Navarro V, Tebé C, Nadal M, Formiga F, Salazar R, Borràs JM.

Oncologist. 2017 Aug;22(8):934-943. doi: 10.1634/theoncologist.2016-0462. Epub 2017 May 9.

16.

The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.

Kalsi T, Babic-Illman G, Ross PJ, Maisey NR, Hughes S, Fields P, Martin FC, Wang Y, Harari D.

Br J Cancer. 2015 Apr 28;112(9):1435-44. doi: 10.1038/bjc.2015.120. Epub 2015 Apr 14.

17.

Pharmacology of anticancer drugs in the elderly population.

Wildiers H, Highley MS, de Bruijn EA, van Oosterom AT.

Clin Pharmacokinet. 2003;42(14):1213-42. Review.

PMID:
14606930
18.

Geriatric oncology and palliative medicine.

Haddad A, Shepard D.

Semin Oncol. 2011 Jun;38(3):362-6. doi: 10.1053/j.seminoncol.2011.03.004.

PMID:
21600364
19.

Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.

Pondé N, Dal Lago L, Azim HA Jr.

Expert Rev Anticancer Ther. 2016 Jun;16(6):661-71. doi: 10.1586/14737140.2016.1170595. Epub 2016 Apr 8. Review.

PMID:
27010772
20.

Comprehensive geriatric assessment and its clinical impact in oncology.

Maas HA, Janssen-Heijnen ML, Olde Rikkert MG, Machteld Wymenga AN.

Eur J Cancer. 2007 Oct;43(15):2161-9. Epub 2007 Sep 12. Review.

PMID:
17855074

Supplemental Content

Support Center